Darolutamide has 2 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Rosuvastatin, Rosuvastatin Calcium. Patients taking Darolutamide should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 2
Major (2)
- Darolutamide + Rosuvastatin— Combination increases rosuvastatin exposure. Limit rosuvastatin dose to 5 mg once daily.
- Darolutamide + Rosuvastatin Calcium— Increases rosuvastatin exposure. Limit rosuvastatin dose to 5 mg once daily.